InspireMD Inc
XBER:II2

Watchlist Manager
InspireMD Inc Logo
InspireMD Inc
XBER:II2
Watchlist
Price: 5.843 EUR -2.42% Market Closed
Market Cap: 47.2m EUR

Wall Street
Price Targets

II2 Price Targets Summary
InspireMD Inc

Wall Street analysts forecast II2 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for II2 is 3.921 EUR with a low forecast of 3.451 EUR and a high forecast of 4.484 EUR.

Lowest
Price Target
3.451 EUR
41% Downside
Average
Price Target
3.921 EUR
33% Downside
Highest
Price Target
4.484 EUR
23% Downside
InspireMD Inc Competitors:
Price Targets
688016
Shanghai MicroPort Endovascular MedTech Group Co Ltd
42% Upside
600529
Shandong Pharmaceutical Glass Co Ltd
38% Upside
300622
Doctorglasses Chain Co Ltd
82% Upside
BLCO
Bausch + Lomb Corp
3% Upside
ICUI
ICU Medical Inc
27% Upside
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
21% Upside
ALC
Alcon AG
34% Upside
NEOG
Neogen Corp
8% Upside

Revenue
Forecast

Revenue Estimate
InspireMD Inc

For the last 12 years the compound annual growth rate for InspireMD Inc's revenue is 3%. The projected CAGR for the next 3 years is 77%.

3%
Past Growth
77%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
InspireMD Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
InspireMD Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is II2's stock price target?
Price Target
3.921 EUR

According to Wall Street analysts, the average 1-year price target for II2 is 3.921 EUR with a low forecast of 3.451 EUR and a high forecast of 4.484 EUR.

What is InspireMD Inc's Revenue forecast?
Projected CAGR
77%

For the last 12 years the compound annual growth rate for InspireMD Inc's revenue is 3%. The projected CAGR for the next 3 years is 77%.

Back to Top